Back to shop

Soluplus®

0.00

Clear
-
+

Total:

Description

Soluplus® is an innovative excipient that enables new levels of solubility and bioavailability for poorly soluble active ingredients. Developed specifically for solid solutions, Soluplus® is unique in many ways. Thanks to its high flowability and excellent extrudability, Soluplus® shows superior performance in forming solid solutions, especially in hot melt extrusion processes. This solid solution makes the active pharmaceutical ingredient (API) available in a dissolved state, resulting in improved bioavailability, once in the body. The safety of Soluplus® is documented by a comprehensive range of toxicological data. Soluplus® has already been approved in Europe.

Soluplus® at a glance

  • Outstanding solubilization properties, especially for poorly soluble APIs
  • Enables bioavailability enhancement
  • Ideal for hot melt extrusion and all standard granulation techniques
  • Market proven solution for unique formulation challenges
  • Amphiphilic structure: polymer and solubilizer perfectly combined in one product
  • Molecular weight optimized for superior ASD stability
  • Glass transition temperature optimized for easy processing

Regulatory Documentation US-DMF #23504 (Type IV DMF, containing CMC information). Regulatory Information File (RIF) with equivalent content to an Open Part/Applicants Part of a DMF – US-DMF #23626 (Type V DMF, containing pre-clinical safety data)

Additional information

Manufacturer

BASF

Dosage Form

solid oral dosage forms, Tablets

Function

bioavailability enhancer, film former, Matrices & fillers, solubility enhancer, Surfactant

Synonym

Polyvinyl caprolactampolyvinyl acetate-polyethylene glycol graft co-polymer

Quality

IPEC GMP

Cas-No

402932-23-4

Technical Name

Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer

Documents and Links

Soluplus® Brochure

Download

Soluplus® technical documentation

Download